IMC-Chicago, LLC

Source: SEC Form 13F · as of Mar 2026

IMC-Chicago, LLC holds 79 biotech & pharma companies tracked by BioSniper, totaling $147.3M in value as of Mar 2026 (SEC Form 13F).

Companies held

79

Total value held

$147.3M

CompanySharesValue
NVONovo Nordisk A/S802,198$29.5M
CPRXCATALYST PHARMACEUTICALS, INC.563,670$14.0M
UTHRUNITED THERAPEUTICS Corp22,162$13.1M
ABVXAbivax SA106,143$11.8M
OSCROscar Health Inc.850,444$9.8M
RIOTRiot Platforms, Inc.699,780$8.6M
BCRXBIOCRYST PHARMACEUTICALS INC631,290$6.0M
PRGOPERRIGO Co plc472,311$5.1M
MDGLMADRIGAL PHARMACEUTICALS, INC.7,795$4.1M
TEVATeva Pharmaceutical Industries Limited89,569$2.7M
BNTXBioNTech SE27,571$2.5M
APLSApellis Pharmaceuticals, Inc.59,232$2.4M
GEHCGE HealthCare Technologies Inc.29,364$2.1M
VRTXVERTEX PHARMACEUTICALS INC / MA4,533$2.0M
ZTSZoetis Inc.13,989$1.7M
BAXBaxter International Inc.82,088$1.4M
AXSMAxsome Therapeutics, Inc.7,847$1.3M
ARGXARGENX SE1,747$1.3M
VTRSViatris Inc93,825$1.3M
CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.7,293$1.3M
MOHMolina Healthcare Inc9,112$1.2M
NKTRNEKTAR THERAPEUTICS16,361$1.2M
RGENREPLIGEN CORP9,012$1.1M
GHGuardant Health Inc.11,387$1.1M
DGXQuest Diagnostics Incorporated5,227$1.0M
VKTXViking Therapeutics, Inc.31,426$1.0M
ROIVRoivant Sciences Ltd.32,219$892K
CLOVClover Health Investments Corp.492,898$868K
ABTABBOTT LABORATORIES8,264$848K
HALOHALOZYME THERAPEUTICS, INC.13,072$845K
IBRXImmunityBio, Inc.97,148$745K
QUREuniQure N.V.45,080$737K
INSMINSMED Inc4,472$731K
SUNSUNSET ISLAND GROUP11,243$730K
QGENQIAGEN N.V.18,017$721K
NBIXNEUROCRINE BIOSCIENCES INC4,951$652K
DVADaVita Inc.4,217$648K
INSPInspire Medical Systems Inc.11,518$594K
LNTHLantheus Holdings, Inc.7,755$588K
RYTMRHYTHM PHARMACEUTICALS, INC.6,697$582K
ADMAADMA BIOLOGICS, INC.62,075$559K
ZBHZimmer Biomet Holdings Inc.6,114$553K
PRCTPROCEPT BioRobotics Corporation19,897$498K
ALHCAlignment Healthcare Inc.28,175$496K
CLPTClearPoint Neuro Inc.47,543$433K
INCYIncyte Corp.4,454$419K
KRYSKrystal Biotech, Inc.1,591$411K
HRMYHarmony Biosciences Holdings, Inc.11,765$330K
GMEDGlobus Medical Inc.3,820$329K
INDVIndivior Pharmaceuticals, Inc.10,723$327K
LEGNLegend Biotech Corp17,894$324K
BMRNBIOMARIN PHARMACEUTICAL INC5,600$316K
SRPTSarepta Therapeutics, Inc.13,895$302K
TRVITrevi Therapeutics, Inc.24,324$290K
OGNOrganon & Co.47,531$285K
TECHBIO-TECHNE Corp5,160$270K
TWSTTwist Bioscience Corp5,661$269K
RAREUltragenyx Pharmaceutical Inc.11,919$250K
ALKSAlkermes plc.6,879$243K
CAICaris Life Sciences Inc.12,919$231K
SNDLSNDL Inc.165,332$218K
MLTXMoonLake Immunotherapeutics11,352$212K
BHVNBiohaven Ltd.22,080$187K
NTLAIntellia Therapeutics, Inc.12,771$164K
ARDXARDELYX, INC.24,723$148K
DNAGinkgo Bioworks Holdings Inc.20,501$126K
FRMMFORUM MARKETS Inc39,442$114K
CRONCronos Group Inc.29,442$74K
INOINOVIO PHARMACEUTICALS, INC.37,889$66K
XERSXeris Biopharma Holdings, Inc.10,881$63K
UPXIUPEXI, INC.48,070$47K
CGCCanopy Growth Corp45,504$43K
ACHAccendra Health Inc.18,443$42K
STIMNeuronetics Inc.27,294$40K
MNKDMANNKIND CORP14,238$35K
ALTAltimmune, Inc.10,004$31K
OCGNOcugen, Inc.11,569$21K
MISTMilestone Pharmaceuticals Inc.10,943$13K
OPKOPKO HEALTH, INC.10,874$12K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.